CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-10 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −839 | $22.56 | $19K | 162,240 |
| 2022-03-03 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −6,926 | $23.61 | $164K | 163,079 |
| 2022-02-27 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise | +24,292 | 186,033 | ||
| 2022-02-27 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −10,279 | $24.35 | $250K | 175,754 |
| 2022-02-27 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −2,743 | $24.35 | $67K | 173,011 |
| 2022-02-27 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −3,006 | $24.35 | $73K | 170,005 |
| 2022-02-27 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise · Restricted Share Units | −24,292 | $24.35 | $592K | 0 |
| 2022-02-14 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award · Restricted Share Units | +24,292 | 0 | ||
| 2021-08-27 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −5,017 | $28.95 | $145K | 161,741 |
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise | +60,345 | $14.38 | $868K | 227,103 |
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise | +60,853 | $15.32 | $932K | 287,956 |
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Sale | −121,198 | $31.83 | $3.9M | 166,758 |
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise · Non-Qualified Stock Options (right to purchase) | −60,345 | 0 | ||
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise · Non-Qualified Stock Options (right to purchase) | −60,853 | 0 | ||
| 2021-03-11 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −796 | $32.82 | $26K | 166,758 |
| 2021-03-10 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −21,960 | $32.97 | $724K | 167,554 |
| 2021-03-08 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise | +8,455 | 163,534 | ||
| 2021-03-08 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award | +25,980 | 189,514 | ||
| 2021-03-08 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise · Restricted Share Units | −8,455 | 0 | ||
| 2021-03-03 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award | +36,250 | 155,079 |
Page 1 of 2 · 39 trades